Article
Pre-clinical validation of a novel pan-cancer CAR-T cell immunotherapy against nfP2X7
2021-12-01
Abstract excerpt
<title>Abstract</title> <p>Chimeric antigen receptor (CAR)-T immunotherapy is a novel treatment that genetically modifies the patient’s own T cells to target and kill malignant cells. CAR-T cells demonstrated robust clinical activity against certain B-cell malignancies. However, identification of tumour-specific antigens expressed on multiple cancer types, especially on solid cancers, remains a major challenge. P...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b356c833-bf0c-57c7-af24-b9a0ac7f594f
- DOI
- 10.21203/rs.3.rs-1073214/v1
